ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 755464 Null 0.0483128986658396 0.36432711
NSC 756355 GW794607X 0.0483128986658396 0.1730282
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.0483128986658396 0.07374186
NSC 761826 (Z)-3-((1-(4-fluoro-3-methoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0483128986658396 0.19534472
NSC 105014 Cladribine 0.0490935610249067 0.22052347
NSC 13151 Null 0.0490935610249067 0.41793718
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0490935610249067 0.23872167
NSC 154948 M-AMSA 0.0490935610249067 0.39402254
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0490935610249067 0.18931827
NSC 303861 L-Cysteine analog 0.0490935610249067 0.57888029
Total:139  Current:131    [First] [Prev] [Next] [Last]